Praxis Precision Medicines, Inc. Profile Avatar - Palmy Investing

Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA rec…

Biotechnology
US, Boston [HQ]

Insiders

Transactions

Track non-derivative insider transactions.
i = Indirect d = Direct cs = Common Stock
Reported Owner(s) Position Now Transaction Date Type Position Change Extra
Statistics
Sample Size: 0 Transactions
Sale (S)
0
0.00%
Buy (P)
0
0.00%
100.00%
Other Ownership

Individuals

We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: